Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Oncogenic Biogenesis of pri-miR-17∼92 Reveals Hierarchy and Competition among Polycistronic MicroRNAs.

Ariel O Donayo | Radia M Johnson | Hsin-Wei Tseng | Said Izreig | Alexandra Gariepy | Vinay K Mayya | Edlyn Wu | Roshni Alam | Carine Lussier | Russell G Jones | Thomas F Duchaine
Molecular cell | 2019

The microRNAs encoded by the miR-17∼92 polycistron are commonly overexpressed in cancer and orchestrate a wide range of oncogenic functions. Here, we identify a mechanism for miR-17∼92 oncogenic function through the disruption of endogenous microRNA (miRNA) processing. We show that, upon oncogenic overexpression of the miR-17∼92 primary transcript (pri-miR-17∼92), the microprocessor complex remains associated with partially processed intermediates that aberrantly accumulate. These intermediates reflect a series of hierarchical and conserved steps in the early processing of the pri-miR-17∼92 transcript. Encumbrance of the microprocessor by miR-17∼92 intermediates leads to the broad but selective downregulation of co-expressed polycistronic miRNAs, including miRNAs derived from tumor-suppressive miR-34b/c and from the Dlk1-Dio3 polycistrons. We propose that the identified steps of polycistronic miR-17∼92 biogenesis contribute to the oncogenic re-wiring of gene regulation networks. Our results reveal previously unappreciated functional paradigms for polycistronic miRNAs in cancer.

Pubmed ID: 31253575

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


IRDye 800CW Goat anti-Rabbit IgG (antibody)

RRID:AB_621843

This polyclonal secondary targets IgG

View all literature mentions

TRBP antibody (antibody)

RRID:AB_1143286

This polyclonal targets Human TRBP

View all literature mentions

V5 Epitope Tag (antibody)

RRID:AB_159313

This monoclonal targets Detects recombinant proteins containing the 14 amino acid V5 epitope

View all literature mentions

DGCR8 C-terminal antibody (antibody)

RRID:AB_2090987

This polyclonal targets DGCR8 C-terminal

View all literature mentions

alpha Tubulin antibody [DM1A] - Loading Control (antibody)

RRID:AB_2241126

This monoclonal targets alpha Tubulin antibody [DM1A] - Loading Control

View all literature mentions

Drosha antibody - ChIP Grade (antibody)

RRID:AB_2301218

This polyclonal targets RNASEN

View all literature mentions

REC-1 (cell line)

RRID:CVCL_1884

Cell line REC-1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

NIH 3T3 (cell line)

RRID:CVCL_0594

Cell line NIH 3T3 is a Spontaneously immortalized cell line with a species of origin Mus musculus

View all literature mentions

SU-DHL-4 (cell line)

RRID:CVCL_0539

Cell line SU-DHL-4 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

OCI-Ly7 (cell line)

RRID:CVCL_1881

Cell line OCI-Ly7 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293T (cell line)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions